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We describe an adaptation of automated multiple flowinjection analysis instrumentation to an analysis for albumin in serum. The bromcresol green reaction was used to test the utility of the system. The approach yielded albumin results with excellent sensitivity, no measurable carryover, a relative standard deviation of less than 1 %, good correlations with published procedures, and no measurable interferences.
The simplicity and flexibility of the instrumentation and its performance integrity, as indicated by the analytical results, make this a viable clinical chemical tool.
Unsegmented continuous-flow analysis, commonly known as flow-injection analysis, was first described by two independent groups of workers (1) (2) (3) (4) and has been recently reviewed by Betteridge (5) . In this reaction system, the reagents and samples flow continuously (5) , without bubble-segmentation. The use of small-bore tubing (0.5 mm i.d.), low-volume fittings and flow cells, and high linear-flow rates gives excellent mixing and maintains sample integrity. Readings return to baseline between samples, at rates greater than 120 samples per hour, with no loss of precision, which is in contrast to the conventional continuous-flow system of Skeggs (6) . With the use of the automatic sampling system of Skeggs and a sample-insertion valve to inject measured volumes of sample into the reaction system, an automated version of flow-injection analysis-automated multiple flow-injection analysis (AMFIA) 
Materials and Methods

Apparatus
The AMFIA instrument used has been described previously by Stewart et al. (3, 15) . A flow diagram for the determination of albumin is shown in Figure   1 . The timing coil after the Mention of a trademark or proprietary product does not constitute a guarantee or warranty of the product by the U.S. Department of Agriculture, and does not imply its approval to the exclusion of other products that may also be suitable. 
Procedures
In all studies we used a fixed order for the first four cups on the 40-position sampler tray: 0, 20, 40, and 60 g/L albumin standards. 
Results
Instrument Setup
Optimization of the instrument performance involved choosing a workable sample size and throughput rate. The flow rates of the reagent and diluent were fixed to maintain the flow velocities necessary for a minimum dispersion within the tubing of the manifold.
With the flow rates listed above, we first tried sample sizes of 100 and 20 tL; however, analysis of the standards revealed a distinctly curvilinear relation between concentration and absorbance, to the extent that the 43 and 63 g/L albumin standards yielded virtually the same relative absorbance (integrated peak areas). With the 2-zL sample size we obtained the standard curve shown in Figure  2 . Although the figure reveals some curvature, we used it because the sample volume limit of the valve had been reached and the curve showed reasonable relative absorbance changes (from the integrated peak area measurements) with respect to changes in albumin concentration (13.9 counts per milligram of albumin per liter). The mixing appeared to improve with the decrease in sample size. Brief reproducibility studies (n = 10) on a serum pool with 32 g of albumin per liter at the various sample volumes revealed relative standard deviations of 2.1% for the 100-1zL sample, 1.2% for the 20-zL sample, and 0.8% for the 2-tL sample. The sample throughput rate of 120 per hour was chosen as a convenient rate of analysis that showed no apparent carryover between samples (see Discussion). The total reaction time of 14 s was chosen to conform to previously published data (10) . No further attempts at optimization were made.
Carryover
The carryover in the instrument can be appreciated by studying Figure 3 , an illustration of the recorder tracing from the first part of an analysis. The figure includes four peaks from the standards, in cups 1 through 4, a saline blank sample in cup 5, and five peaks from the low-concentration serum pool in cups 6 through 10. The return to baseline of the tracing after each standard or sample has gone through the system is clear, with approximately 10 s required for the recorder to return to zero after the peak maximum. The complete lack of a peak for the saline blank serves to further underscore the low carryover from the AMFIA instrument (see Discussion).
We further assessed the carryover of the instrument by alternating the saline blank samples with samples from a serum pool of high albumin concentration.
The sensitivity of the recorder was increased 10-fold so that a nominal absorbance of 0.1 would be a full-scale deflection.
At this setting the peak for the pool sample went off-scale (nominal absorbance of the pool sample was 0.6), but no measurable pen deflection was observed for the saline blank samples. The return of the recorder pen to baseline between samples was also evaluated at this recorder setting, and the return clearly showed that washout of the 2-zL sample was complete within lOs after the peak maximum was reached.
Precision
To evaluate the precision of the AMFIA system, we ana- 
Correlation
The results of the comparison studies involving patients' sera are listed in Table 1 , and the data for the AMFIA method 
Blank and Interferences
To determine the contribution from sample blanks, we reanalyzed 35 of the samples used in the correlation study, substituting saline for the BCG reagent. The samples were selected to represent the 10 to 50 g/L albumin concentration range seen, moderate hemolysis (only slightly but obviously pink), and mild lipemia (slightly cloudy but not separated into layers). The baseline on the recorder remained steady through the running of these samples, and the peak-area integrator detected no peaks, showing that blanks produced no measurable signals. Thus neither moderate hemolysis nor mild lipemia interfered with the AMFIA procedure.
Discussion
The results from the AMFIA system measurements of al- in the analysis of a 2-L sample was excellent. We feel confident that samples of 1-FL or smaller could be used (with an appropriate sampling valve) and that this change would further improve the linearity of the standard curve. This is suggested by the improvement in linearity we observed in going from 100-and 20-fzL sample sizes to the 2-tL sample size. A provision for sample predilution might also improve the linearity of the standard curve, but we did not do this in the present study because we felt it would increase the dispersion of the flow system (5) and detract from the analytical performance.
The flexibility of the instrument should also be noted. To change reaction times from seconds to longer delay times involves simply incorporating of different delay coils into the manifold.
The BCG-albumin reaction underscores this advantage, because several authors using the bubble-segmented continuous-flow analyzer have documented that reaction times longer than 14s result in an apparent bias in the albumin assay (12) (13) (14) (16) (17) (18) (19) . Increasing the reaction time by longer delay coils would also increase the system dispersion, and would thus change system performance.
Of course the importance of these changes would have to be assessed with respect to the analysis requirements.
The flexibility of the analysis time is certainly a strong point of the AMFIA system and could allow its application to any number of clinical analyses.
The sampling frequency of 120 per hour was chosen for convenience. The lack of carryover and the excellent precision suggest that the system throughput could probably be increased to higher numbers as reported previously (2) (3) (4) (5) 15) . The lack of carryover improved our confidence in the analytical data and again underscores the elegance of the instrumentation.
It is important to note that because of the sampling valve, carryover must be assessed by testing the entire analysis procedure.
We chose to alternate a blank sample with a serum sample of high albumin concentration to see whether carryover was measurable. Failure to measure any carryover in this circumstance enhanced our confidence in the low carryover of the method.
The abandonment of reliance on steady-state analytical response and bubble segmentation is inviting. The concepts embodied in the AMFIA approach are akin to those of chromatographic-flow systems and include reliance on a carefully measured sample aliquot and controlled, reproducible dispersion. The reproducibility of the AMFIA results and the excellent agreement with the assays made by a traditional continuous-flow analyzer and the centrifugal analyzer illustrate the utility of the flow-injection concept in the clinical chemistry laboratory.
